Group One Trading
GEVA

Group One Trading’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Group One Trading’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-27,600
Closed -$2.69M – 5549
2015
Q1 		$2.69M Buy
27,600
+26,100
+1,740% +$2.76M 0.04% 497
2014
Q4 		$139K Sell
1,500
-500
-25% -$39.5K ﹤0.01% 2591
2014
Q3 		$138K Buy
2,000
+200
+11% +$14.3K ﹤0.01% 2717
2014
Q2 		$189K Sell
1,800
-8,000
-82% -$681K ﹤0.01% 2462
2014
Q1 		$813K Buy
9,800
+9,100
+1,300% +$841K 0.01% 1242
2013
Q4 		$45K Buy
700
+600
+600% +$35.6K ﹤0.01% 3709
2013
Q3 		$6K Buy
+100
New +$4.92K ﹤0.01% 4725

Group One Trading's GEVA Position: Q2 2015 in Review

Group One Trading sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 3,677 shares — an estimated $359K sold.

Group One Trading first reported a position in GEVA in Q3 2013 and held it in 6 quarters. The position peaked at $1.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Group One Trading reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Group One Trading sold 3,677 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $359K.
  • Group One Trading first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2013 and held it in 6 quarters.
  • Group One Trading's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Group One Trading's 13F filing for Q2 2015, filed 11 Aug 2015.